Literature DB >> 29539137

Calprotectin Expression in Human Monocytes: Induction by Porphyromonas gingivalis Lipopolysaccharide, Tumor Necrosis Factor-α, and Interleukin-1β.

Jun-Ichi Kido1, Noriko Hayashi1, Masatoshi Kataoka2, Toshihiko Nagata1.   

Abstract

BACKGROUND: Calprotectin is a major cytosolic protein of monocytes and granulocytes. It is increased in inflammatory tissues and is detected at high levels in the gingival crevicular fluid (GCF) of periodontitis patients. We previously reported that lipopolysaccharide of Porphyromonas gingivalis (P-LPS) and cytokines induced the release of calprotectin from monocytes isolated from human peripheral blood. The mechanisms of calprotectin expression and presence of its regulation factors in periodontal disease are unknown. On the other hand, P-LPS and cytokines are significant etiologic factors in the initiation and progression of periodontal diseases. In this study, we investigated the expression and production of calprotectin from human monocytes by examining the effects of lipopolysaccharide of P-LPS, tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β).
METHODS: Monocytes were isolated from the peripheral blood of healthy donors and cultured in the presence or absence of P-LPS, TNF-α, or IL-1β. The expressions of calprotectin mRNAs (MRP8 and MRP14) were detected by Northern blotting. The contents of calprotectin in the cells and medium fractions were determined by enzyme-linked immunosorbent assay (ELISA). The DNA binding activity of C/EBPα, a transcription factor of MRP14, was assessed by electrophoretic mobility shift DNA-binding assay (EMSA).
RESULTS: P-LPS, TNF-α, and IL-1β induced MRP8/14 mRNAs and calprotectin production in monocytes. These factors also induced DNA CEBPα binding activity in monocytes. P-LPS increased MRP14 mRNA expression in monocytes to the maximum level, about two times the control level after 24 hours treatment, but did not enhance the basal level of MRP8. When the effects of TNF-α and IL-1β on those mRNAs were investigated, both MRP8 and MRP14 significantly increased to about 2- and 2.5-fold the control level, respectively. Increases of MRP8/14 mRNA expression were followed by their protein production at about 2-fold the basal amount. DNA binding activity of C/EBPα was increased in P-LPS, TNF-α, and IL-1β-treated monocytes.
CONCLUSIONS: These results demonstrate that P-LPS, TNF-α, and IL-1β induce calprotectin production from human monocytes and that this production is associated with the activation of DNA C/EBPα binding complex. J Periodontol 2005;76:437-442.
© 2005 American Academy of Periodontology.

Entities:  

Keywords:  Calprotectin; Porphyromonas gingivalis; interleukin-1β; lipopolysaccharides; monocytes; tumor necrosis factor

Year:  2005        PMID: 29539137     DOI: 10.1902/jop.2005.76.3.437

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  4 in total

1.  Combined Administration of Curcumin and Chondroitin Sulfate Alleviates Cartilage Injury and Inflammation via NF-κB Pathway in Knee Osteoarthritis Rats.

Authors:  Ting Guan; Liu-Gang Ding; Bao-Yuan Lu; Jia-Yi Guo; Mei-Yin Wu; Zhi-Qun Tan; Shao-Zhen Hou
Journal:  Front Pharmacol       Date:  2022-05-19       Impact factor: 5.988

Review 2.  Role of Calprotectin as a Biomarker in Periodontal Disease.

Authors:  Lili Wei; Mingwen Liu; Haofei Xiong
Journal:  Mediators Inflamm       Date:  2019-08-21       Impact factor: 4.711

3.  Comparison of salivary calprotectin levels in periodontitis associated with diabetes mellitus after low-level laser therapy as an adjunct to scaling and root planing: A randomized clinical trial.

Authors:  Sai Ankitha Kamatham; Vijay Kumar Chava
Journal:  J Indian Soc Periodontol       Date:  2022-03-01

4.  Sustained exposure to systemic endotoxin triggers chemokine induction in the brain followed by a rapid influx of leukocytes.

Authors:  Carolyn A Thomson; Alison McColl; Gerard J Graham; Jonathan Cavanagh
Journal:  J Neuroinflammation       Date:  2020-03-25       Impact factor: 8.322

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.